Healthcare
Phio Pharma
Upcoming June 29, 2026
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
EDV is developing a non-invasive drug delivery platform to transport therapeutics directly to the inner ear via ear drops
A proven, proprietary, scalable technology for converting organic waste into the building blocks of Sustainable Aviation Fuel
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
Vessel Wave Technologies is addressing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis